Physical Activity and Community EmPOWERment Project
University of North Carolina, Chapel Hill · with National Institute on Aging (NIA) · NCT06740162
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 376
- US sites recruiting
- 1
- Study start
- January 10, 2025
- Record last updated
- February 23, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Purpose: Conduct a wait-list randomized controlled trial (RCT) of an inclusive physical activity program called PACE for adults with intellectual disability (ID) who are not yet showing signs of Alzheimer's Disease (AD)/age-related dementias (ARD).
Participants: Participants include 120 adults with ID, their caregivers, and their coaches (up to 360 individual participants, grouped as triads), recruited through the University of North Carolina at Chapel Hill and the University of Arkansas. Participants also include 16 exercise professionals.
Procedures (methods): Each cohort will include 20 triads who are randomly assigned to the PACE program or the waitlist control group.
Being studied: PACE Program
Conditions: Intellectual Disability; Neurodevelopmental Disorders; Autism Spectrum Disorder; Down Syndrome; Fragile X Syndrome; Cri-du-Chat Syndrome; De Lange Syndrome; Mental Retardation, X-Linked; Prader-Willi Syndrome; Rubinstein-Taybi Syndrome; Trisomy 13 Syndrome; WAGR Syndrome; Williams Syndrome
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion criteria for adults with ID will include:
- ages 18 and older with a prior clinical diagnosis of ID, confirmed by scores \< 70 and + 90% on the Leiter-3 International Performance Scales and/or an adaptive behavior measure using the Vineland Adaptive Behavior Scales,
- Medical clearance to participate in moderate-to-vigorous physical activity as determined by the American College of Sports Medicine (ACSM) preparticipation algorithm,
- Adult does not show clinically elevated symptoms of Alzheimer's Disease (AD)/ Alzheimer's Disease and Related Dementias (ADRD) as indicated by a score of \< 20 on the Dementia Screening Questionnaire for Individuals with Intellectual Disabilities.
- One caregiver/guardian is able and willing to participate.
- must tolerate at least 8 hours of daily wear-time of Actigraph device during initial assessment period (4 of 7 days),
- must average 20 minutes or less of moderate to vigorous physical activity (MVPA) minutes per day (140 MVPA minutes or less across 7-day period measured during the initial assessment period, and
- must reside in North Carolina or Arkansas.
Exclusion Criteria for adults with ID
- Diagnosis of AD, dementia, or related disorders. Participants will not be excluded based on gender, race, or ethnicity. There will be no upper age limit due to the heterogeneity of onset of AD/ADRD in individuals with ID.
Inclusion criteria for coach will include
- access to the internet and a mobile device,
- has weekly contact with the adult participant with ID,
- can converse and read in English to comprehend intervention materials and website content, and
- must reside in North Carolina or Arkansas
Inclusion criteria for caregiver will include:
- ability to converse and read in English to comprehend and answer interview questions, (2) must care for an adult with ID who is willing to participate in the study,
- must reside in North Carolina or Arkansas, and
- must attend all study visits with adult with ID.
Recruiting US locations
University of North Carolina
Chapel Hill, NC 27517
Site contact: Brianne R Tomaszewski, Ph.D., MPH · 919-962-8563 · Brianne_Tomaszewski@med.unc.edu
Study contacts (from the official record)
- Brianne R Tomaszewski, PhD, MPH · 919-962-8563 · Brianne_Tomaszewski@med.unc.edu
- Kara Hume, PhD · 919-843-2291 · kara.hume@unc.edu
Similar studies in North Carolina
All neurology studies in North Carolina →- RecruitingHealthy volunteersPhase 1
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SIF001 in Healthy Subjects and in Epilepsy Patients
Suninflam Inc
- Location
- Charlotte, NC + 9 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteers
Aimovig Pregnancy Exposure Registry
Amgen
- Location
- Durham, NC
- Eligibility basics
- Ages 18–99 · Women only
- RecruitingPhase 1/Phase 2
A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome
Encoded Therapeutics
- Location
- Durham, NC + 9 other US sites
- Eligibility basics
- Ages 6 mo–17
- RecruitingPhase 3
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
TG Therapeutics, Inc.
- Location
- Charlotte, NC + 35 other US sites
- Eligibility basics
- Ages 18–65